Australia's largest stock trading and investment forum Australia's #1 stock forum

VLA viralytics limited

0.00%

$1.75

Ann: Viralytics and Merck Collaborate in Lung and Bladder Cancer, page-9

First 9 Last

Share
Profile

Follow
kates9999

15,357 Posts.

694

06/11/15

12:21

Post #: 16339322
Share

Originally posted by georges ↑

Intravenous delivery. The real potential for Cavatak has always been intravenous delivery. Until this stage Cavatak has only been shown to work by direct injection into a lesion. While a big market, small in comparison to the markets of lung and bladder and probably many others.
Merck will have looked closely at the early stage Intravenous results and they must be impressive for Merck to join a combination trial.
Cavatak/Viralytics is no longer just a direct injection into melanoma product. It is a combination treatment for major cancers which is publicly recognised by a player as big as Merck.
It may take the Australian market a while to wake up to this but watch the VRACY price react in the US tonight.

Expand

Massive announcement
And I've seen take overs in phase 1 (not saying it would happen) but it has happened before

Guess this will be the big player realistically

VLA Price at posting: 58.5¢ Sentiment: Hold Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

AII

A new NASDAQ listing for a key player in the global critical minerals space

BDM

Burgundy plunges -20% after turning to layoffs to navigate record-low diamond prices

Listen: HotCopper Wire Podcast 018 – Potatoes, TACOs, and the $120M helicopter heist

PSC

Prospect's Mumbezhi Project puts it at the middle of copper's megatrend. And FQM just bought in

SYR

Syrah jumps +19% as graphite tariff threat spurs optimism down under

Week 29 Wrap: ASX hits new all time high of 8,766pts ahead of Aug 1

SER

Strategic Energy extends its QLD copper-gold frontier with Diamantina acquisition

STN

Saturn brings up seventh straight Apollo Hill upgrade on 'impressive' 300-hole drill run

HotCopper Highlights: Trigg; Droneshield; Lumos & more

DRO

History repeats for DroneShield investors but carnage so far subdued

First 9 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Ann: Viralytics and Merck Collaborate in Lung and Bladder Cancer, page-9

Top Stories

A new NASDAQ listing for a key player in the global critical minerals space

Burgundy plunges -20% after turning to layoffs to navigate record-low diamond prices

Listen: HotCopper Wire Podcast 018 – Potatoes, TACOs, and the $120M helicopter heist

Prospect's Mumbezhi Project puts it at the middle of copper's megatrend. And FQM just bought in

Syrah jumps +19% as graphite tariff threat spurs optimism down under

Week 29 Wrap: ASX hits new all time high of 8,766pts ahead of Aug 1

Strategic Energy extends its QLD copper-gold frontier with Diamantina acquisition

Saturn brings up seventh straight Apollo Hill upgrade on 'impressive' 300-hole drill run

HotCopper Highlights: Trigg; Droneshield; Lumos & more

History repeats for DroneShield investors but carnage so far subdued

Featured News